Wikidata

(Q53523902)

English

Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer: searching for the maximal tolerated dose.

scientific article

In more languages

Statements

title
Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer: searching for the maximal tolerated dose. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10776983
retrieved
15 May 2018
reference URL
http://europepmc.org/abstract/MED/10776983

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53523902&oldid=1628765763"